Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, an androgen receptor blocker, significantly increased hair density, thickness, and length in monkeys when applied topically daily for several months.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Ruxolitinib treatment may cause eyelash growth.

High doses of ethynylestradiol in rats caused growth issues, organ changes, and some tumors, but didn't increase overall tumor rates.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Finasteride may reduce depression and anxiety in female rats and improve brain connectivity.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

New compounds may help treat prostate issues without affecting androgen receptors.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Finasteride helps treat frontal fibrosing alopecia, improving or stabilizing the condition in many patients.

A 5-year-old girl with McCune-Albright syndrome grew abnormal hair due to the drug tamoxifen.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Finasteride with oral contraceptive improves hair loss in 62% of premenopausal women.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The combination tablet of finasteride and doxazosin works the same as taking each drug separately.

Spironolactone helps prevent swelling caused by minoxidil in women with hair loss.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.